BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 16027229)

  • 1. MEN16132, a novel potent and selective nonpeptide kinin B2 receptor antagonist: in vivo activity on bradykinin-induced bronchoconstriction and nasal mucosa microvascular leakage in anesthetized guinea pigs.
    Valenti C; Cialdai C; Giuliani S; Lecci A; Tramontana M; Meini S; Quartara L; Maggi CA
    J Pharmacol Exp Ther; 2005 Nov; 315(2):616-23. PubMed ID: 16027229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MEN16132, a kinin B2 receptor antagonist, prevents the endogenous bradykinin effects in guinea-pig airways.
    Valenti C; Cialdai C; Giuliani S; Tramontana M; Quartara L; Maggi CA
    Eur J Pharmacol; 2008 Jan; 579(1-3):350-6. PubMed ID: 18036587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Intra-articular 4-(S)-amino-5-(4-{4-[2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido]-tetrahydro-2H-4-pyranylcarbonyl} piperazino)-5-oxopentyl](trimethyl)ammonium chloride hydrochloride (MEN16132), a kinin B2 receptor antagonist, on nociceptive response in monosodium iodoacetate-induced experimental osteoarthritis in rats.
    Cialdai C; Giuliani S; Valenti C; Tramontana M; Maggi CA
    J Pharmacol Exp Ther; 2009 Dec; 331(3):1025-32. PubMed ID: 19745108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MEN16132, a novel potent and selective nonpeptide antagonist for the human bradykinin B2 receptor. In vitro pharmacology and molecular characterization.
    Cucchi P; Meini S; Bressan A; Catalani C; Bellucci F; Santicioli P; Lecci A; Faiella A; Rotondaro L; Giuliani S; Giolitti A; Quartara L; Maggi CA
    Eur J Pharmacol; 2005 Dec; 528(1-3):7-16. PubMed ID: 16324696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences between peptide and nonpeptide B(2) bradykinin receptor antagonists in blocking bronchoconstriction and hypotension induced by bradykinin in anesthetized Guinea pigs.
    Tramontana M; Lecci A; Meini S; Montserrat X; Pascual J; Giuliani S; Quartara L; Maggi CA
    J Pharmacol Exp Ther; 2001 Mar; 296(3):1051-7. PubMed ID: 11181940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bradykinin-induced lung inflammation and bronchoconstriction: role in parainfluenze-3 virus-induced inflammation and airway hyperreactivity.
    Broadley KJ; Blair AE; Kidd EJ; Bugert JJ; Ford WR
    J Pharmacol Exp Ther; 2010 Dec; 335(3):681-92. PubMed ID: 20847038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of FR173657, a non-peptide B2 antagonist, on kinin-induced hypotension, visceral and peripheral oedema formation and bronchoconstriction.
    Griesbacher T; Legat FJ
    Br J Pharmacol; 1997 Mar; 120(5):933-9. PubMed ID: 9138701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of novel sulfonamide-containing bradykinin hB2 receptor antagonists. 2. Synthesis and structure-activity relationships of alpha,alpha-cycloalkylglycine sulfonamides.
    Fattori D; Rossi C; Fincham CI; Caciagli V; Catrambone F; D'Andrea P; Felicetti P; Gensini M; Marastoni E; Nannicini R; Paris M; Terracciano R; Bressan A; Giuliani S; Maggi CA; Meini S; Valenti C; Quartara L
    J Med Chem; 2007 Feb; 50(3):550-65. PubMed ID: 17266207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the receptor and the mechanisms underlying the inflammatory response induced by des-Arg9-BK in mouse pleurisy.
    Vianna RM; Calixto JB
    Br J Pharmacol; 1998 Jan; 123(2):281-91. PubMed ID: 9489617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of the bradykinin B2 receptor antagonist MEN16132 in rat in vitro bioassays.
    Meini S; Cucchi P; Catalani C; Bellucci F; Giuliani S; Santicioli P; Maggi CA
    Eur J Pharmacol; 2009 Aug; 615(1-3):10-6. PubMed ID: 19445925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S 16118 (p-guanidobenzoyl-[Hyp3,Thi5,D-Tic7,Oic8]bradykinin) is a potent and long-acting bradykinin B2 receptor antagonist, in vitro and in vivo.
    Félétou M; Robineau P; Lonchampt M; Bonnardel E; Thurieau C; Fauchère JL; Widdowson P; Mahieu JP; Serkiz B; Volland JP
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1071-7. PubMed ID: 7791077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Hoe 140 on bradykinin-induced bronchoconstriction in anesthetized guinea pigs.
    Wirth KJ; Gehring D; Schölkens BA
    Am Rev Respir Dis; 1993 Sep; 148(3):702-6. PubMed ID: 8368643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation modifies the role of cyclooxygenases in the contractile responses of the rat detrusor smooth muscle to kinin agonists.
    Meini S; Lecci A; Cucchi P; Catalioto RM; Criscuoli M; Maggi CA
    J Pharmacol Exp Ther; 1998 Oct; 287(1):137-43. PubMed ID: 9765332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the non-peptide B2 antagonist FR173657 on kinin-induced smooth muscle contraction and relaxation, vasoconstriction and prostaglandin release.
    Griesbacher T; Sametz W; Legat FJ; Diethart S; Hammer S; Juan H
    Br J Pharmacol; 1997 Jun; 121(3):469-76. PubMed ID: 9179388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The identification of an orally active, nonpeptide bradykinin B2 receptor antagonist, FR173657.
    Asano M; Inamura N; Hatori C; Sawai H; Fujiwara T; Katayama A; Kayakiri H; Satoh S; Abe Y; Inoue T; Sawada Y; Nakahara K; Oku T; Okuhara M
    Br J Pharmacol; 1997 Feb; 120(4):617-24. PubMed ID: 9051299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the bradykinin B2 receptor antagonist S 16118 (p-guanidobenzoyl-[Hyp3,Thi5,D-Tic7,Oic8]bradykinin) in different in vivo animal models of inflammation.
    Félétou M; Lonchampt M; Robineau P; Jamonneau I; Thurieau C; Fauchère JL; Villa P; Ghezzi P; Prost JF; Canet E
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1078-84. PubMed ID: 7791078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo activity of analogues of the kinin B2 receptor antagonist MEN1 1270.
    Meini S; Lecci A; Carini F; Tramontana M; Giuliani S; Maggi CA; Ricci R; Fabbri G; Anichini B; Harmat N; Rizzi A; Camarda V; Regoli D; Quartara L
    Can J Physiol Pharmacol; 2002 Apr; 80(4):293-302. PubMed ID: 12025964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of an orally active non-peptide bradykinin B2 receptor antagonist, FR173657, on plasma exudation in rat carrageenin-induced pleurisy.
    Majima M; Kawashima N; Hiroshi I; Katori M
    Br J Pharmacol; 1997 Jun; 121(4):723-30. PubMed ID: 9208140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MEN 11270, A novel selective constrained peptide antagonist with high affinity at the human B2 kinin receptor.
    Meini S; Quartara L; Rizzi A; Patacchini R; Cucchi P; Giolitti A; Calò G; Regoli D; Criscuoli M; Maggi CA
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1250-6. PubMed ID: 10336513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proinflammatory characteristics of a nonpeptide bradykinin mimic, FR190997, in vivo.
    Hayashi I; Ishihara K; Kumagai Y; Majima M
    Br J Pharmacol; 2001 Aug; 133(8):1296-306. PubMed ID: 11498515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.